Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Novel delivery strategies for glioblastoma.

Zhou J, Atsina KB, Himes BT, Strohbehn GW, Saltzman WM.

Cancer J. 2012 Jan-Feb;18(1):89-99. doi: 10.1097/PPO.0b013e318244d8ae. Review.

2.

Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.

Karim R, Palazzo C, Evrard B, Piel G.

J Control Release. 2016 Apr 10;227:23-37. doi: 10.1016/j.jconrel.2016.02.026. Epub 2016 Feb 16. Review.

PMID:
26892752
3.

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE.

Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6. Review.

PMID:
25791797
4.

Imaging of convection enhanced delivery of toxins in humans.

Mehta AI, Choi BD, Raghavan R, Brady M, Friedman AH, Bigner DD, Pastan I, Sampson JH.

Toxins (Basel). 2011 Mar;3(3):201-6. doi: 10.3390/toxins3030201. Epub 2011 Mar 15. Review.

5.

Drug delivery approaches for the treatment of glioblastoma multiforme.

Fakhoury M.

Artif Cells Nanomed Biotechnol. 2016 Sep;44(6):1365-73. doi: 10.3109/21691401.2015.1052467. Epub 2015 Jun 5. Review.

PMID:
26046399
6.

Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.

Oberoi RK, Parrish KE, Sio TT, Mittapalli RK, Elmquist WF, Sarkaria JN.

Neuro Oncol. 2016 Jan;18(1):27-36. doi: 10.1093/neuonc/nov164. Epub 2015 Sep 10. Review.

7.

Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.

Kim SS, Harford JB, Pirollo KF, Chang EH.

Biochem Biophys Res Commun. 2015 Dec 18;468(3):485-9. doi: 10.1016/j.bbrc.2015.06.137. Epub 2015 Jun 24. Review.

8.

Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.

Juratli TA, Schackert G, Krex D.

Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18. Review.

PMID:
23694764
9.

Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.

Drapeau A, Fortin D.

Curr Cancer Drug Targets. 2015;15(9):752-68. Review.

PMID:
26077730
10.

Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.

Agarwal S, Sane R, Oberoi R, Ohlfest JR, Elmquist WF.

Expert Rev Mol Med. 2011 May 13;13:e17. doi: 10.1017/S1462399411001888. Review.

11.

Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.

Suwala AK, Hanaford A, Kahlert UD, Maciaczyk J.

J Neuropathol Exp Neurol. 2016 May;75(5):388-96. doi: 10.1093/jnen/nlw013. Epub 2016 Mar 15. Review.

PMID:
26979081
12.

Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.

Ung TH, Malone H, Canoll P, Bruce JN.

CNS Oncol. 2015;4(4):225-34. doi: 10.2217/cns.15.12. Epub 2015 Jun 24. Review.

PMID:
26103989
13.

Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.

Ferguson S, Lesniak MS.

Curr Drug Deliv. 2007 Apr;4(2):169-80. Review.

PMID:
17456036
14.

Novel drug delivery strategies in neuro-oncology.

Bidros DS, Vogelbaum MA.

Neurotherapeutics. 2009 Jul;6(3):539-46. doi: 10.1016/j.nurt.2009.04.004. Review.

15.

STAT3 as a Therapeutic Target for Glioblastoma.

Liu Y, Li C, Lin J.

Anticancer Agents Med Chem. 2010 Sep;10(7):512-9. Review.

PMID:
20879983
16.
17.

Targeted drug delivery for treatment and imaging of glioblastoma multiforme.

Stukel JM, Caplan MR.

Expert Opin Drug Deliv. 2009 Jul;6(7):705-18. doi: 10.1517/17425240902988470. Review.

PMID:
19538036
18.

Glioblastoma Multiforme and Lipid Nanocapsules: A Review.

Aparicio-Blanco J, Torres-Suárez AI.

J Biomed Nanotechnol. 2015 Aug;11(8):1283-311. Review.

PMID:
26295134
19.

Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: A review.

Mujokoro B, Adabi M, Sadroddiny E, Adabi M, Khosravani M.

Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:1092-102. doi: 10.1016/j.msec.2016.07.080. Epub 2016 Aug 1. Review.

PMID:
27612807
20.

Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics.

Katsetos CD, Draber P, Kavallaris M.

Anticancer Agents Med Chem. 2011 Oct;11(8):719-28. Review.

PMID:
21707498

Supplemental Content

Support Center